Elena R. Radchenko
Research Subjects
Research Interests
Elena R. Radchenko has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Irina N. Zakharova
Russian Medical Academy of Continuous Professional Education
8 shared publications - Yuliya A. Dmitrieva
Russian Medical Academy of Continuous Professional Education; Bashlyaeva Children’s City Clinical Hospital
8 shared publications - Ismail M. Osmanov
Bashlyaeva City Children’s Clinical Hospital; Pirogov Russian National Research Medical University
6 shared publications - Irina D. Maykova
Bashlyaeva Children's City Clinical Hospital
4 shared publications - Anastasia D. Gostyukhina
Russian Medical Academy of Continuous Professional Education; Bashlyaeva Children’s City Clinical Hospital
3 shared publications - Antonina S. Stadnikova
Bashlyaeva City Children’s Clinical Hospital
3 shared publications
Latest Publications
- Open Access
- 15 December 2024
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 4,p. 379-385
Autoimmune polyglandular syndrome type 1 in children: A clinical case
The autoimmune polyglandular syndrome is a rare autoimmune disease characterized by simultaneous primary involvement of the endocrine glands and other organs. It is caused by a defect in the AutoImmune REgulator (AIRE) gene. The paper presents data on autoimmune polyglandular syndrome type 1, including the frequency of its occurrence, features of the clinical presentation, course, and prognosis. In the described clinical case, we present patient management with this syndrome, features of the disease course, the challenges of diagnosis and therapy choice, and the need for follow-up observation.
- 15 December 2024
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 4,p. 379-385
Open AccessAutoimmune polyglandular syndrome type 1 in children: A clinical case
The autoimmune polyglandular syndrome is a rare autoimmune disease characterized by simultaneous primary involvement of the endocrine glands and other organs. It is caused by a defect in the AutoImmune REgulator (AIRE) gene. The paper presents data on autoimmune polyglandular syndrome type 1, including the frequency of its occurrence, features of the clinical presentation, course, and prognosis. In the described clinical case, we present patient management with this syndrome, features of the disease course, the challenges of diagnosis and therapy choice, and the need for follow-up observation.
- Open Access
- 24 October 2024
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 2,p. 120-129
Are pediatricians aware of the mysterious FPIES? Current diagnostic and treatment options. Case report
The prevalence of food allergies continues to grow steadily, and due to certain difficulties in diagnosing allergies not associated with immunoglobulin E, some conditions are little known. Such diagnosis-challenging diseases include food protein-induced enterocolitis syndrome (FPIES), a relatively low-prevalence disease most commonly occurring in early childhood but, in some cases, affecting adults as well. The pathogenesis of FPIES has not been reliably studied. FPIES is associated with elevated serum tryptase and release of pro-inflammatory cytokines, including interleukin-17. A characteristic symptom of FPIES is uncontrollable vomiting, which is probably triggered by the serotonin secreted by enterochromaffin cells, which activates the vagus nerve and the vomiting reflex, determining a good response of vomiting relief with ondansetron, a serotonin receptor antagonist. Changes in gut microbiota composition were also reported in FPIES. FPIES can lead to severe complications such as hypovolemic shock due to the rapid progression of symptoms and rapid dehydration, which often requires hospitalization of patients with acute FPIES. The provoking factors usually include products from the "big nine" allergens: cow's milk, eggs, gluten, soy, nuts, peanuts, fish, seafood, and sesame. FPIES can be acute or chronic; the manifestations slightly differ depending on the disease form. Laboratory diagnosis is difficult due to the lack of reliable biomarkers, and the diagnosis is established clinically and confirmed with an oral provocation test. The key treatment for FPIES is to eliminate the trigger protein from the diet, and depending on the severity of the disease, some patients may be allowed to consume a heat-treated allergen. The prognosis of FPIES is favorable: tolerance to the trigger product in most cases is developed within two years. Further studies are required to clarify the pathogenesis, prevalence, and treatment methods, with prospective follow-up of patients with a history of FPIES and the analysis of concurrent and subsequent diseases, including allergic conditions. The article presents two clinical cases of children diagnosed with FPIES.
- 24 October 2024
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 2,p. 120-129
Open AccessAre pediatricians aware of the mysterious FPIES? Current diagnostic and treatment options. Case report
The prevalence of food allergies continues to grow steadily, and due to certain difficulties in diagnosing allergies not associated with immunoglobulin E, some conditions are little known. Such diagnosis-challenging diseases include food protein-induced enterocolitis syndrome (FPIES), a relatively low-prevalence disease most commonly occurring in early childhood but, in some cases, affecting adults as well. The pathogenesis of FPIES has not been reliably studied. FPIES is associated with elevated serum tryptase and release of pro-inflammatory cytokines, including interleukin-17. A characteristic symptom of FPIES is uncontrollable vomiting, which is probably triggered by the serotonin secreted by enterochromaffin cells, which activates the vagus nerve and the vomiting reflex, determining a good response of vomiting relief with ondansetron, a serotonin receptor antagonist. Changes in gut microbiota composition were also reported in FPIES. FPIES can lead to severe complications such as hypovolemic shock due to the rapid progression of symptoms and rapid dehydration, which often requires hospitalization of patients with acute FPIES. The provoking factors usually include products from the "big nine" allergens: cow's milk, eggs, gluten, soy, nuts, peanuts, fish, seafood, and sesame. FPIES can be acute or chronic; the manifestations slightly differ depending on the disease form. Laboratory diagnosis is difficult due to the lack of reliable biomarkers, and the diagnosis is established clinically and confirmed with an oral provocation test. The key treatment for FPIES is to eliminate the trigger protein from the diet, and depending on the severity of the disease, some patients may be allowed to consume a heat-treated allergen. The prognosis of FPIES is favorable: tolerance to the trigger product in most cases is developed within two years. Further studies are required to clarify the pathogenesis, prevalence, and treatment methods, with prospective follow-up of patients with a history of FPIES and the analysis of concurrent and subsequent diseases, including allergic conditions. The article presents two clinical cases of children diagnosed with FPIES.
- Open Access
- 24 October 2024
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 2,p. 162-166
Selective screening for celiac disease in patients with gastrointestinal symptoms: a retrospective study
Background. Currently, the effectiveness of various screening programs for celiac disease remains a matter of debate. According to most researchers, selective screening among patients with characteristic symptoms or at-risk groups is most effective. Aim. To evaluate the effectiveness of selective screening for celiac disease in patients with gastrointestinal symptoms. Materials and methods. In an open retrospective clinical study, the rate of celiac disease among 1,482 children who were examined in the Bashlyaeva Children's City Clinical Hospital and the most significant symptoms of the disease depending on age were identified. Results. The mean rate of celiac disease was 8.26%: from 6 months to 3 years 7.25%, from 4 to 7 years 10.28%, from 8 to 14 years 9.33%, and in adolescents from 15 years and older 4.05%. The most significant symptoms of the disease in young children were abdominal distension/flatulence, asthenia, and weight loss; preschool children had stool disorders (constipation, diarrhea), abdominal distension/flatulence, and anemia. At the age of 8–14 years, only nausea was statistically significantly associated with celiac disease. We have not identified any significant symptoms in the older age group. Conclusion. Our study has shown the high effectiveness of selective screening for celiac disease. The selective screening program is most effective in children of early and preschool age, which defines this age category as a target for introducing screening programs in medical check-ups before enrollment to preschool institutions and schools.
- 24 October 2024
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 2,p. 162-166
Open AccessSelective screening for celiac disease in patients with gastrointestinal symptoms: a retrospective study
Background. Currently, the effectiveness of various screening programs for celiac disease remains a matter of debate. According to most researchers, selective screening among patients with characteristic symptoms or at-risk groups is most effective. Aim. To evaluate the effectiveness of selective screening for celiac disease in patients with gastrointestinal symptoms. Materials and methods. In an open retrospective clinical study, the rate of celiac disease among 1,482 children who were examined in the Bashlyaeva Children's City Clinical Hospital and the most significant symptoms of the disease depending on age were identified. Results. The mean rate of celiac disease was 8.26%: from 6 months to 3 years 7.25%, from 4 to 7 years 10.28%, from 8 to 14 years 9.33%, and in adolescents from 15 years and older 4.05%. The most significant symptoms of the disease in young children were abdominal distension/flatulence, asthenia, and weight loss; preschool children had stool disorders (constipation, diarrhea), abdominal distension/flatulence, and anemia. At the age of 8–14 years, only nausea was statistically significantly associated with celiac disease. We have not identified any significant symptoms in the older age group. Conclusion. Our study has shown the high effectiveness of selective screening for celiac disease. The selective screening program is most effective in children of early and preschool age, which defines this age category as a target for introducing screening programs in medical check-ups before enrollment to preschool institutions and schools.
- Open Access
- 24 October 2024
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 2,p. 138-144
Collagenous enteritis as a rare cause of exudative enteropathy in a child. Case report
Exudative enteropathy (EE) syndrome can be associated with various diseases of the gastrointestinal tract (GIT) and is manifested by edematous syndrome, hypoproteinemia, hypoalbuminemia, lymphocytopenia, hypogammaglobulinemia, and an increase in the level of α-1-antitrypsin in the feces. More than 60 medical conditions are associated with loss of protein through the gastrointestinal tract, including erosive-ulcerative diseases of the gastrointestinal tract, non-erosive lesions of the mucous membrane causing an increase in the permeability of the intestinal wall, as well as disorders with an increase in pressure in the lymphatic system. Correct diagnosis and timely replacement and pathogenetic therapy are essential for the rapid cessation of pathological losses, the recovery of the proteinogram, and the prevention of life-threatening complications. Collagenous enteritis is one of the rare diseases of the small intestine associated with EE syndrome. The article presents a clinical case of a young child with EE and collagenous enteritis. The stages of the diagnostic workup in detecting EE syndrome in the child are discussed, and the pathogenetic factors that determined the development of this disorder are considered.
- 24 October 2024
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 2,p. 138-144
Open AccessCollagenous enteritis as a rare cause of exudative enteropathy in a child. Case report
Exudative enteropathy (EE) syndrome can be associated with various diseases of the gastrointestinal tract (GIT) and is manifested by edematous syndrome, hypoproteinemia, hypoalbuminemia, lymphocytopenia, hypogammaglobulinemia, and an increase in the level of α-1-antitrypsin in the feces. More than 60 medical conditions are associated with loss of protein through the gastrointestinal tract, including erosive-ulcerative diseases of the gastrointestinal tract, non-erosive lesions of the mucous membrane causing an increase in the permeability of the intestinal wall, as well as disorders with an increase in pressure in the lymphatic system. Correct diagnosis and timely replacement and pathogenetic therapy are essential for the rapid cessation of pathological losses, the recovery of the proteinogram, and the prevention of life-threatening complications. Collagenous enteritis is one of the rare diseases of the small intestine associated with EE syndrome. The article presents a clinical case of a young child with EE and collagenous enteritis. The stages of the diagnostic workup in detecting EE syndrome in the child are discussed, and the pathogenetic factors that determined the development of this disorder are considered.
- Open Access
- 9 August 2024
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 11,p. 180-187
Diagnostic value of serological markers for celiac disease in children
Introduction. Serologic tests are the main tool to screen for celiac disease. The serologic tests for tissue transglutaminase (tTG-IgA) antibodies combined with the assessment of the total serum IgA concentration is recommended as a primary test. Other serological markers, in particular IgA and/or IgG antibodies against deamidated gliadin peptides (DGP-IgG/IgA) and native gliadin (AGA-IgA/IgG), are not recommended for use in diagnosing celiac disease in immunocompetent patients.Aim. To determine the diagnostic value of serological markers during the initial examination for celiac disease in children.Materials and methods. The sensitivity, specificity, positive and negative predictive value of tTG-IgA/IgG, DPG-IgA/IgG, AGA-IgA/IgG were calculated for a group of 1247 children.Results. Celiac disease was diagnosed in 101 patients of the study group. Tissue transglutaminase IgA antibodies demonstrated the highest sensitivity, specificity, positive and negative predictive values of 98.02, 99.48, 94.29 and 99.82%, respectively. DPG-IgA/IgG, AGA-IgA were inferior in sensitivity and specificity to tTG-IgA, the positive predictive value of DGP-IgG and AGA-IgA was 34.62 and 34.21%, respectively. AGA-IgG showed the worst specificity (40.3%) and positive predictive values (12.41%).Discussion The low predictive value of the positive results of AGA IgA and DPG IgG determines the extremely high percentage of false-positive results for these tests. In none of the cases of an isolated elevation in AGA and DPG antibodies the diagnosis of celiac disease was confirmed, if tissue transglutaminase IgA antibody concentrations were normal.Conclusion. The results of our study are fully consistent with the position of modern clinical guidelines, demonstrating the maximum diagnostic value of tissue transglutaminase IgA antibody during examination for celiac disease. Other antibodies are not recommended for use in the screening process to avoid unnecessary referrals of patients for endoscopic examination and to reduce healthcare costs.
- 9 August 2024
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 11,p. 180-187
Open AccessDiagnostic value of serological markers for celiac disease in children
Introduction. Serologic tests are the main tool to screen for celiac disease. The serologic tests for tissue transglutaminase (tTG-IgA) antibodies combined with the assessment of the total serum IgA concentration is recommended as a primary test. Other serological markers, in particular IgA and/or IgG antibodies against deamidated gliadin peptides (DGP-IgG/IgA) and native gliadin (AGA-IgA/IgG), are not recommended for use in diagnosing celiac disease in immunocompetent patients.Aim. To determine the diagnostic value of serological markers during the initial examination for celiac disease in children.Materials and methods. The sensitivity, specificity, positive and negative predictive value of tTG-IgA/IgG, DPG-IgA/IgG, AGA-IgA/IgG were calculated for a group of 1247 children.Results. Celiac disease was diagnosed in 101 patients of the study group. Tissue transglutaminase IgA antibodies demonstrated the highest sensitivity, specificity, positive and negative predictive values of 98.02, 99.48, 94.29 and 99.82%, respectively. DPG-IgA/IgG, AGA-IgA were inferior in sensitivity and specificity to tTG-IgA, the positive predictive value of DGP-IgG and AGA-IgA was 34.62 and 34.21%, respectively. AGA-IgG showed the worst specificity (40.3%) and positive predictive values (12.41%).Discussion The low predictive value of the positive results of AGA IgA and DPG IgG determines the extremely high percentage of false-positive results for these tests. In none of the cases of an isolated elevation in AGA and DPG antibodies the diagnosis of celiac disease was confirmed, if tissue transglutaminase IgA antibody concentrations were normal.Conclusion. The results of our study are fully consistent with the position of modern clinical guidelines, demonstrating the maximum diagnostic value of tissue transglutaminase IgA antibody during examination for celiac disease. Other antibodies are not recommended for use in the screening process to avoid unnecessary referrals of patients for endoscopic examination and to reduce healthcare costs.
- Open Access
- 17 April 2023
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 6,p. 193-200
The recurrent course of atopic dermatitis: therapeutic options for management of disease and prolongation of remissions
Atopic dermatitis is a common inflammatory skin disease, which is most frequently occurred in children. The disease is characterized as chronic, but only 20% of children have severe atopic dermatitis, while the other 80% achieve a long-term remission by the age of 8. The article summarizes the main details about atopic dermatitis, including statistical epidemiological data, signs of a severe course of atopic dermatitis, criteria for determining the severity of the disease and the main aspects of a stepwise approach to the therapy. The authors paid special attention to the factors worsening the course of atopic dermatitis: the role of allergens and provoking factors, secondary infection, drug hypersensitivity, concomitant diseases, breach of dermatologist’s prescriptions. Despite the large arsenal of modern therapeutic methods, the therapy of a long, persistent course of atopic dermatitis may not produce a proper effect, and this is the reason why the disease acquires a torpid course. Such clinical cases call for finding new therapeutic methods, in particular the use of Janus kinase inhibitors. In the article, the authors described a clinical case: a 17-year-old patient K. complained of widespread rashes on the skin of the trunk accompanied by intense itching; the patient had been suffering from atopic dermatitis since early childhood, the skin process had a recurrent character with alternating periods of remissions and exacerbations about 2 times a year. The case describes the successful use of Janus kinase inhibitor that was capable to reduce the signaling of many cytokines that contribute to the development of signs and symptoms of the disease, in a patient with severe relapsing atopic dermatitis, who showed insufficient efficacy of therapy with standard methods.
- 17 April 2023
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 6,p. 193-200
Open AccessThe recurrent course of atopic dermatitis: therapeutic options for management of disease and prolongation of remissions
Atopic dermatitis is a common inflammatory skin disease, which is most frequently occurred in children. The disease is characterized as chronic, but only 20% of children have severe atopic dermatitis, while the other 80% achieve a long-term remission by the age of 8. The article summarizes the main details about atopic dermatitis, including statistical epidemiological data, signs of a severe course of atopic dermatitis, criteria for determining the severity of the disease and the main aspects of a stepwise approach to the therapy. The authors paid special attention to the factors worsening the course of atopic dermatitis: the role of allergens and provoking factors, secondary infection, drug hypersensitivity, concomitant diseases, breach of dermatologist’s prescriptions. Despite the large arsenal of modern therapeutic methods, the therapy of a long, persistent course of atopic dermatitis may not produce a proper effect, and this is the reason why the disease acquires a torpid course. Such clinical cases call for finding new therapeutic methods, in particular the use of Janus kinase inhibitors. In the article, the authors described a clinical case: a 17-year-old patient K. complained of widespread rashes on the skin of the trunk accompanied by intense itching; the patient had been suffering from atopic dermatitis since early childhood, the skin process had a recurrent character with alternating periods of remissions and exacerbations about 2 times a year. The case describes the successful use of Janus kinase inhibitor that was capable to reduce the signaling of many cytokines that contribute to the development of signs and symptoms of the disease, in a patient with severe relapsing atopic dermatitis, who showed insufficient efficacy of therapy with standard methods.
- Open Access
- 18 January 2023
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 4,p. 361-365
Celiac disease: history and modern era
Celiac disease is one of the oldest human diseases, dating back to the Neolithic Era with the advent of the farming culture. In over 10,000 years, celiac disease has evolved from an unknown and frightening "sickness of the coeliac" to one of the most common genetically determined conditions with a thoroughly understood pathogenesis and effective treatment. Current epidemiological data suggest that the global prevalence of celiac disease averages 1%, with most cases unrecognized. Given the diversity of clinical manifestations, a selective screening program for celiac disease among patients with some suspicious symptoms proved its value only partially. Most experts point to the need for universal screening to effectively detect asymptomatic forms of celiac disease and early initiation of nutritional therapy to avoid serious complications.
- 18 January 2023
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 4,p. 361-365
Open AccessCeliac disease: history and modern era
Celiac disease is one of the oldest human diseases, dating back to the Neolithic Era with the advent of the farming culture. In over 10,000 years, celiac disease has evolved from an unknown and frightening "sickness of the coeliac" to one of the most common genetically determined conditions with a thoroughly understood pathogenesis and effective treatment. Current epidemiological data suggest that the global prevalence of celiac disease averages 1%, with most cases unrecognized. Given the diversity of clinical manifestations, a selective screening program for celiac disease among patients with some suspicious symptoms proved its value only partially. Most experts point to the need for universal screening to effectively detect asymptomatic forms of celiac disease and early initiation of nutritional therapy to avoid serious complications.
- Open Access
- 1 January 2022
- Published by NP Rusmedical Group in Doctor.Ru
- Vol. 21 (7)
Eosinophilic Gastritis in a Child. How to Suspect? Diagnostic Criteria
Objective of the Review: To analyze current data on eosinophilic lesions of the stomach in children with the analysis of a clinical case. Key points. Diseases of the gastrointestinal tract associated with primary tissue eosinophilia are a heterogeneous group of changes characterized by inflammation, with predominantly eosinophilic tissue infiltration in the absence of other known causes. Clinical manifestations of allergic inflammatory diseases of the gastrointestinal tract are most often nonspecific. Depending on the level of the lesion, eosinophils are distinguished: gastritis (EoG), enteritis, and colitis. In recent years, more and more attention of experts has been directed to research in this area, but so far there are no general epidemiological data on the prevalence of this pathology in the population, both adults and children. Conclusion. Currently, there are no clear morphological criteria for diagnosing eosinophilic lesions of the stomach, small and large intestine in children, and clinical manifestations, especially in young children, are nonspecific. When making a diagnosis of EoG, it is necessary to take into account a family allergic history, a set of laboratory diagnostic data (eosinophilia in a clinical blood test and a high level of total IgE) and a morphological study of a biopsy of the gastric mucosa. Keywords: children, eosinophilic gastritis, eosinophilia, tissue eosinophilia, food allergy.
- 1 January 2022
- Published by NP Rusmedical Group in Doctor.Ru
- Vol. 21 (7)
Open AccessEosinophilic Gastritis in a Child. How to Suspect? Diagnostic Criteria
Objective of the Review: To analyze current data on eosinophilic lesions of the stomach in children with the analysis of a clinical case. Key points. Diseases of the gastrointestinal tract associated with primary tissue eosinophilia are a heterogeneous group of changes characterized by inflammation, with predominantly eosinophilic tissue infiltration in the absence of other known causes. Clinical manifestations of allergic inflammatory diseases of the gastrointestinal tract are most often nonspecific. Depending on the level of the lesion, eosinophils are distinguished: gastritis (EoG), enteritis, and colitis. In recent years, more and more attention of experts has been directed to research in this area, but so far there are no general epidemiological data on the prevalence of this pathology in the population, both adults and children. Conclusion. Currently, there are no clear morphological criteria for diagnosing eosinophilic lesions of the stomach, small and large intestine in children, and clinical manifestations, especially in young children, are nonspecific. When making a diagnosis of EoG, it is necessary to take into account a family allergic history, a set of laboratory diagnostic data (eosinophilia in a clinical blood test and a high level of total IgE) and a morphological study of a biopsy of the gastric mucosa. Keywords: children, eosinophilic gastritis, eosinophilia, tissue eosinophilia, food allergy.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 21 (5)
Typical and atypical forms of pyoderma in children: differential diagnosis challenges
Среди инфекционных заболеваний кожи детского возраста наиболее часто встречаются гнойничковые воспалительные заболевания — пиодермии, количество форм которой огромно. Авторы обращают внимание на факторы, способствующие развитию пиодермий в раннем детском возрасте. К ним относятся анатомические и функциональные особенности строения кожи у детей, характеристики врожденного и приобретенного иммунитета, а также агрессивное влияние окружающей среды. Подробно описан каждый из факторов. Представлена классификация пиодермий по возбудителю, вызвавшему заболеванию, глубине поражения, времени появления, а также по длительности течения инфекционного процесса. В детской возрасте наиболее характерны острые поверхностные, а не глубокие хронические, формы пиодермий. Они отличаются контагиозностью и быстрым распространением инфекционного процесса. Контагиозное импетиго — самое распространенное гнойничковое воспалительное заболевание детского возраста. Представлены общие сведения об этиологии, описаны клинические проявления буллезного и небуллезного импетиго у детей. Уделено внимание принципам терапии пиодермий у детей, а также представлено собственное клиническое наблюдение лечения стрептококкового импетиго кожи периоральной области у ребенка с использованием мази, содержащей хлорамфеникол.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 21 (5)
Typical and atypical forms of pyoderma in children: differential diagnosis challenges
Среди инфекционных заболеваний кожи детского возраста наиболее часто встречаются гнойничковые воспалительные заболевания — пиодермии, количество форм которой огромно. Авторы обращают внимание на факторы, способствующие развитию пиодермий в раннем детском возрасте. К ним относятся анатомические и функциональные особенности строения кожи у детей, характеристики врожденного и приобретенного иммунитета, а также агрессивное влияние окружающей среды. Подробно описан каждый из факторов. Представлена классификация пиодермий по возбудителю, вызвавшему заболеванию, глубине поражения, времени появления, а также по длительности течения инфекционного процесса. В детской возрасте наиболее характерны острые поверхностные, а не глубокие хронические, формы пиодермий. Они отличаются контагиозностью и быстрым распространением инфекционного процесса. Контагиозное импетиго — самое распространенное гнойничковое воспалительное заболевание детского возраста. Представлены общие сведения об этиологии, описаны клинические проявления буллезного и небуллезного импетиго у детей. Уделено внимание принципам терапии пиодермий у детей, а также представлено собственное клиническое наблюдение лечения стрептококкового импетиго кожи периоральной области у ребенка с использованием мази, содержащей хлорамфеникол.
- Open Access
- 21 July 2021
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 4,p. 170-177
Gluten-free diet for neurological and psychiatric diseases: is it worth expecting an effect?
Gluten represents an alcohol- soluble fraction of endosperm proteins of some cereals (wheat, rye, barley). The molecular characteristics of gluten, in particular, the high content of proline in the composition, determines its high resistance to human gastric, pancreatic and intestinal enzymes. Accordingly, gluten peptides retain their immunogenicity when they enter the internal environment of the body, which determines their ability to activate both the innate and adaptive immune response, and maintain pathological immune- mediated reactions that underlie the complex of gluten- associated diseases and pathological conditions. The question of how gluten consumption may be associated with various neurological disorders continues to be discussed. Despite the lack of sufficient objective evidence, the peculiarities of gliadin metabolism suggest the possibility of an association between the consumption of gluten- containing products with the development of neuropsychiatric disorders.. Of particular interest is the efficacy of gluten-free diet in the complex therapy of such diseases as autism, schizophrenia, as well as some neurological disorders, including chronic fatigue syndrome, various cognitive impairments, depression, etc. The article presents a number of research results, as well as discusses the potential mechanisms of the neurotropic action of gluten. The article discusses the potential metabolic and immunological mechanisms of the neurotropic action of gluten, analyzes the literature data regarding the effectiveness of a gluten-free diet in various neurological diseases and psychiatric disorders.
- 21 July 2021
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 4,p. 170-177
Open AccessGluten-free diet for neurological and psychiatric diseases: is it worth expecting an effect?
Gluten represents an alcohol- soluble fraction of endosperm proteins of some cereals (wheat, rye, barley). The molecular characteristics of gluten, in particular, the high content of proline in the composition, determines its high resistance to human gastric, pancreatic and intestinal enzymes. Accordingly, gluten peptides retain their immunogenicity when they enter the internal environment of the body, which determines their ability to activate both the innate and adaptive immune response, and maintain pathological immune- mediated reactions that underlie the complex of gluten- associated diseases and pathological conditions. The question of how gluten consumption may be associated with various neurological disorders continues to be discussed. Despite the lack of sufficient objective evidence, the peculiarities of gliadin metabolism suggest the possibility of an association between the consumption of gluten- containing products with the development of neuropsychiatric disorders.. Of particular interest is the efficacy of gluten-free diet in the complex therapy of such diseases as autism, schizophrenia, as well as some neurological disorders, including chronic fatigue syndrome, various cognitive impairments, depression, etc. The article presents a number of research results, as well as discusses the potential mechanisms of the neurotropic action of gluten. The article discusses the potential metabolic and immunological mechanisms of the neurotropic action of gluten, analyzes the literature data regarding the effectiveness of a gluten-free diet in various neurological diseases and psychiatric disorders.